Company intelligence / Profile preview

Bioinfogate

Barcelona, Spain

Ownership: Private
Development stage: Other

Overview

Bioinfogate developed the OFF-X platform, now the largest translational safety and toxicity intelligence portal for drugs and pharmacological targets, curated to support drug safety assessment throughout preclinical and clinical R&D. The platform integrates safety intelligence from nearly 14,500 drugs and biologics, covering 15,000 targets, and is continuously updated to support risk assessment and clinical trial safety decisions. Bioinfogate itself was not a therapeutics developer.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Bioinfogate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioinfogate.

Explore the full profile